Cargando…
Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats
BACKGROUND: Cisplatin (CP) is commonly used in the treatment of different types of cancer but nephrotoxicity has been a major limiting factor. Therefore, the present study aimed to study the possible protective effect of rutin against nephrotoxicity induced by cisplatin in rats. METHODS: Forty male...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472980/ https://www.ncbi.nlm.nih.gov/pubmed/28619064 http://dx.doi.org/10.1186/s12882-017-0601-y |
_version_ | 1783244221614915584 |
---|---|
author | Alhoshani, Ali R. Hafez, Mohamed M. Husain, Sufia Al-sheikh, Abdel Malek Alotaibi, Moureq R. Al Rejaie, Salim S. Alshammari, Musaad A. Almutairi, Mashal M. Al-Shabanah, Othman A. |
author_facet | Alhoshani, Ali R. Hafez, Mohamed M. Husain, Sufia Al-sheikh, Abdel Malek Alotaibi, Moureq R. Al Rejaie, Salim S. Alshammari, Musaad A. Almutairi, Mashal M. Al-Shabanah, Othman A. |
author_sort | Alhoshani, Ali R. |
collection | PubMed |
description | BACKGROUND: Cisplatin (CP) is commonly used in the treatment of different types of cancer but nephrotoxicity has been a major limiting factor. Therefore, the present study aimed to study the possible protective effect of rutin against nephrotoxicity induced by cisplatin in rats. METHODS: Forty male Wistar albino rats were randomly divided into 4 groups. Rats of group 1 control group intraperitoneal (i.p.) received 2.5 ml/kg, group 2 CP group received single dose 5 mg/kg cisplatin i.p. group 3 rutin group orally received 30 mg/kg rutin group 4 (CP plus rutin) received CP and rutin as in group 2 and 3. Kidneys were harvested for histopathology and for the study the gene expression of c-Jun N-terminal kinases (JNK), Mitogen-activated protein kinase 4 (MKK4), MKK7, P38 mitogen-activated protein kinases (P38), tumor necrosis factors alpha (TNF-α), TNF Receptor-Associated Factor 2 (TRAF2), and interleukin-1 alpha (IL-1-α). RESULTS: The cisplatin single dose administration to rats induced nephrotoxicity associated with a significant increase in blood urea nitrogen (BUN) and serum creatinine and significantly increase Malondialdehyde (MDA) in kidney tissues by 230 ± 5.5 nmol/g compared to control group. The animal treated with cisplatin showed a significant increase in the expression levels of the IL-1α (260%), TRFA2 (491%), P38 (410%), MKK4 (263%), MKK7 (412%), JNK (680%) and TNF-α (300%) genes compared to control group. Additionally, histopathological examination showed that cisplatin-induced interstitial congestion, focal mononuclear cell inflammatory, cell infiltrate, acute tubular injury with reactive atypia and apoptotic cells. Rutin administration attenuated cisplatin-induced alteration in gene expression and structural and functional changes in the kidney. Additionally, histopathological examination of kidney tissues confirmed gene expression data. CONCLUSION: The present study suggested that the anti-oxidant and anti-inflammatory effect of rutin may prevent CP-induced nephrotoxicity via decreasing the oxidative stress, inhibiting the interconnected ROS/JNK/TNF/P38 MAPK signaling pathways, and repairing the histopathological changes against cisplatin administration. |
format | Online Article Text |
id | pubmed-5472980 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54729802017-06-21 Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats Alhoshani, Ali R. Hafez, Mohamed M. Husain, Sufia Al-sheikh, Abdel Malek Alotaibi, Moureq R. Al Rejaie, Salim S. Alshammari, Musaad A. Almutairi, Mashal M. Al-Shabanah, Othman A. BMC Nephrol Research Article BACKGROUND: Cisplatin (CP) is commonly used in the treatment of different types of cancer but nephrotoxicity has been a major limiting factor. Therefore, the present study aimed to study the possible protective effect of rutin against nephrotoxicity induced by cisplatin in rats. METHODS: Forty male Wistar albino rats were randomly divided into 4 groups. Rats of group 1 control group intraperitoneal (i.p.) received 2.5 ml/kg, group 2 CP group received single dose 5 mg/kg cisplatin i.p. group 3 rutin group orally received 30 mg/kg rutin group 4 (CP plus rutin) received CP and rutin as in group 2 and 3. Kidneys were harvested for histopathology and for the study the gene expression of c-Jun N-terminal kinases (JNK), Mitogen-activated protein kinase 4 (MKK4), MKK7, P38 mitogen-activated protein kinases (P38), tumor necrosis factors alpha (TNF-α), TNF Receptor-Associated Factor 2 (TRAF2), and interleukin-1 alpha (IL-1-α). RESULTS: The cisplatin single dose administration to rats induced nephrotoxicity associated with a significant increase in blood urea nitrogen (BUN) and serum creatinine and significantly increase Malondialdehyde (MDA) in kidney tissues by 230 ± 5.5 nmol/g compared to control group. The animal treated with cisplatin showed a significant increase in the expression levels of the IL-1α (260%), TRFA2 (491%), P38 (410%), MKK4 (263%), MKK7 (412%), JNK (680%) and TNF-α (300%) genes compared to control group. Additionally, histopathological examination showed that cisplatin-induced interstitial congestion, focal mononuclear cell inflammatory, cell infiltrate, acute tubular injury with reactive atypia and apoptotic cells. Rutin administration attenuated cisplatin-induced alteration in gene expression and structural and functional changes in the kidney. Additionally, histopathological examination of kidney tissues confirmed gene expression data. CONCLUSION: The present study suggested that the anti-oxidant and anti-inflammatory effect of rutin may prevent CP-induced nephrotoxicity via decreasing the oxidative stress, inhibiting the interconnected ROS/JNK/TNF/P38 MAPK signaling pathways, and repairing the histopathological changes against cisplatin administration. BioMed Central 2017-06-15 /pmc/articles/PMC5472980/ /pubmed/28619064 http://dx.doi.org/10.1186/s12882-017-0601-y Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Alhoshani, Ali R. Hafez, Mohamed M. Husain, Sufia Al-sheikh, Abdel Malek Alotaibi, Moureq R. Al Rejaie, Salim S. Alshammari, Musaad A. Almutairi, Mashal M. Al-Shabanah, Othman A. Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats |
title | Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats |
title_full | Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats |
title_fullStr | Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats |
title_full_unstemmed | Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats |
title_short | Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats |
title_sort | protective effect of rutin supplementation against cisplatin-induced nephrotoxicity in rats |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472980/ https://www.ncbi.nlm.nih.gov/pubmed/28619064 http://dx.doi.org/10.1186/s12882-017-0601-y |
work_keys_str_mv | AT alhoshanialir protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats AT hafezmohamedm protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats AT husainsufia protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats AT alsheikhabdelmalek protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats AT alotaibimoureqr protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats AT alrejaiesalims protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats AT alshammarimusaada protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats AT almutairimashalm protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats AT alshabanahothmana protectiveeffectofrutinsupplementationagainstcisplatininducednephrotoxicityinrats |